{"entity":{"type":"insider","cik":"0001825799","url":"/insider/0001825799","json_url":"/insider/0001825799.json","name":"Englese Thomas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2021-12-15","last":"2023-03-09","span_basis":"filed_date"},"name_variants":[{"name":"Englese Thomas","source":"filing","n_filings":3,"first_seen":"2021-12-15","last_seen":"2023-03-09"}],"transactions":[{"id":8561203,"accession":"0001415889-23-004626","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-004626","line_url":"/filing/0001415889-23-004626#line-2","is_derivative":false,"issuer_cik":"0001708527","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001708527","owner_cik":"0001825799","owner_name":"Englese Thomas","owner_url":"/insider/0001825799","role":"Officer (CHIEF COMMERCIAL OFFICER)","officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":289.0,"shares_display":"289","price_per_share":4.3,"price_display":"4.30","price_state":"stated","total_value":1242.7,"total_display":"1,242.70","shares_owned_after":17917.0,"shares_owned_after_display":"17,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-09","filed_date":"2023-03-09","scope":"insider"},{"id":6835893,"accession":"0001415889-22-002868","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-002868","line_url":"/filing/0001415889-22-002868#line-2","is_derivative":false,"issuer_cik":"0001708527","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001708527","owner_cik":"0001825799","owner_name":"Englese Thomas","owner_url":"/insider/0001825799","role":"Officer (CHIEF COMMERCIAL OFFICER)","officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":276.0,"shares_display":"276","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":6607.0,"shares_owned_after_display":"6,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-10","filed_date":"2022-03-10","scope":"insider"},{"id":5447888,"accession":"0001415889-21-005960","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-005960","line_url":"/filing/0001415889-21-005960#line-1","is_derivative":false,"issuer_cik":"0001708527","issuer_name":"AZIYO BIOLOGICS, INC.","issuer_ticker":"AZYO","issuer_name_source":null,"issuer_url":"/issuer/0001708527","owner_cik":"0001825799","owner_name":"Englese Thomas","owner_url":"/insider/0001825799","role":"Officer (CHIEF COMMERCIAL OFFICER)","officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4580.0,"shares_display":"4,580","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":27938.0,"total_display":"27,938.00","shares_owned_after":5088.0,"shares_owned_after_display":"5,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-14","filed_date":"2021-12-15","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001708527","name":"AZIYO BIOLOGICS, INC.","url":"/issuer/0001708527","role":"Officer (CHIEF COMMERCIAL OFFICER)","n_filings":3,"first_seen":"2021-12-15","last_seen":"2023-03-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001825799","retrieved_at":"2026-08-21T04:36:38+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}